July 30, 2015
At PharmaLegacy, Bone disease/Orthopedics scientists are world renown and have cumulated more than a century of experience in bone physiopathology, especially in osteoporosis and orthopedics.
The American Society for Bone and Mineral Research (ASBMR) is a professional, scientific and medical society established to bring together clinical and experimental scientists who are involved in the study of bone and mineral metabolism.
After establishing, PharmaLegacy consistently attended the annual ASBMR meetings ever since 2008. This year we’ll as usual exhibit at the meeting held in Seattle, Washington, USA, Oct 9-12, with the booth #420.
Together with our leading USA BD director Ms. Kathy Kane, our CSO Dr. Mei-Shu Shih will be on site to demonstrate his expertise and insights on IND/IDE filing experience collected during a 15-year CRO career. Our routine and customized animal models, familiarity with 501(k) and SOP driven GLP quality assurance operation, as well standard surgical/engineering procedures, have enabled multiple drug/device candidates to successfully reach the market, and for sure will, aid your regulatory submission in the future.